Vol 7, No 5 (October 01, 2018): Hepatobiliary Surgery and Nutrition

Pattern of disease recurrence and its implications for postoperative surveillance after curative hepatectomy for hepatocellular carcinoma: experience from a single center

Cytokinome of adult-derived human liver stem/progenitor cells: immunological and inflammatory features

Which method of distal pancreatectomy is cost-effective among open, laparoscopic, or robotic surgery?

Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus

New insights into genetic predisposition and novel therapeutic targets for nonalcoholic fatty liver disease

The role of selective internal radiotherapy with Y-90 resin microsphere in first-line therapy for hepatic colorectal metastases

Extended criteria donors in liver transplantation—from marginality to mainstream

Non-alcoholic fatty liver disease: a pandemic disease with multisystem burden

Inspiration of liver resection for hepatocellular carcinoma associated with hepatic vein invasion, not inferior vena cava invasion

Maintenance with single agent bevacizumab fails to improve disease-control in metastatic colorectal cancer

Adjuvant chemotherapy with gemcitabine plus erlotinib vs. gemcitabine alone for patients with resected pancreatic ductal adenocarcinoma: is there a role for erlotinib?—review of the open label phase III trial CONKO 005

Increased mutant KRAS gene dosage drives pancreatic cancer progression: evidence for wild-type KRAS as a tumor suppressor?

Moving from late to early stage disease: lessons learned from erlotinib in pancreatic can

Actively implementing enteral nutrition to reduce parenteral nutrition-associated liver disease

A “reappearance” of gallbladder in a liver transplant recipient

William S. Blaner: successful researchers ought to be exceptionally motivated towards generating new knowledge